A different interpretation of the efficacy of lung cancer screening in the PLCO trial

Eur J Epidemiol. 2016 Feb;31(2):211-2. doi: 10.1007/s10654-015-0070-1. Epub 2015 Jul 22.

Authors

Motoyasu Sagawa¹, Tomio Nakayama², Tomotaka Sobue³; JECS Study Group

Affiliations

¹ Department of Thoracic Surgery, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa, 920-0293, Japan. sagawam@kanazawa-med.ac.jp.
² Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
³ Division of Environmental Medicine and Population Sciences, Graduate School of Medicine, Osaka University, Suita, Japan.

PMID: 26197850
DOI: 10.1007/s10654-015-0070-1

No abstract available

Keywords: Efficacy; Lung cancer screening; Mortality reduction; PLCO.

Publication types

Letter

MeSH terms

Colorectal Neoplasms / diagnosis
Colorectal Neoplasms / prevention & control
Early Detection of Cancer*
Female
Humans
Lung Neoplasms / diagnosis*
Lung Neoplasms / mortality
Lung Neoplasms / prevention & control*
Male
Mass Screening*
Ovarian Neoplasms / diagnosis
Ovarian Neoplasms / prevention & control
Prostatic Neoplasms / diagnosis
Prostatic Neoplasms / prevention & control